

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.83958532 |
| 2 | muscle filament sliding (GO:0030049) | 8.31443925 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.31443925 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.56967698 |
| 5 | cardiac myofibril assembly (GO:0055003) | 7.56962294 |
| 6 | myofibril assembly (GO:0030239) | 7.41343864 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.38947464 |
| 8 | plasma membrane repair (GO:0001778) | 7.10707140 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.03734191 |
| 10 | actin-mediated cell contraction (GO:0070252) | 6.87092216 |
| 11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.61396214 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.44920131 |
| 13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.36847202 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.20577533 |
| 15 | tricarboxylic acid cycle (GO:0006099) | 6.11463430 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.85424224 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 5.71418778 |
| 18 | cardiac muscle cell development (GO:0055013) | 5.67257396 |
| 19 | striated muscle contraction (GO:0006941) | 5.62599688 |
| 20 | actomyosin structure organization (GO:0031032) | 5.60401226 |
| 21 | regulation of actin filament-based movement (GO:1903115) | 5.60179383 |
| 22 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.55161378 |
| 23 | carnitine shuttle (GO:0006853) | 5.44580629 |
| 24 | cardiac cell development (GO:0055006) | 5.33336434 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.33284280 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.32166783 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.31863294 |
| 28 | skeletal muscle contraction (GO:0003009) | 5.21687482 |
| 29 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.14674284 |
| 30 | actin filament-based movement (GO:0030048) | 5.13123885 |
| 31 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.09147041 |
| 32 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.03006399 |
| 33 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.95876082 |
| 34 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.94764713 |
| 35 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.87302713 |
| 36 | adult heart development (GO:0007512) | 4.85704188 |
| 37 | creatine metabolic process (GO:0006600) | 4.72256419 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 4.68877937 |
| 39 | cardiac muscle hypertrophy (GO:0003300) | 4.68170003 |
| 40 | regulation of striated muscle contraction (GO:0006942) | 4.60050290 |
| 41 | heart contraction (GO:0060047) | 4.60030088 |
| 42 | heart process (GO:0003015) | 4.60030088 |
| 43 | regulation of coenzyme metabolic process (GO:0051196) | 4.59339280 |
| 44 | regulation of cofactor metabolic process (GO:0051193) | 4.59339280 |
| 45 | striated muscle hypertrophy (GO:0014897) | 4.52569933 |
| 46 | muscle tissue morphogenesis (GO:0060415) | 4.49486522 |
| 47 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.45254966 |
| 48 | heart trabecula formation (GO:0060347) | 4.44780481 |
| 49 | regulation of sarcomere organization (GO:0060297) | 4.35713106 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.35198303 |
| 51 | skeletal muscle adaptation (GO:0043501) | 4.31632339 |
| 52 | muscle contraction (GO:0006936) | 4.10379758 |
| 53 | carnitine transmembrane transport (GO:1902603) | 4.06554983 |
| 54 | skeletal muscle fiber development (GO:0048741) | 4.04405221 |
| 55 | NADH metabolic process (GO:0006734) | 3.98429320 |
| 56 | muscle hypertrophy (GO:0014896) | 3.98043611 |
| 57 | regulation of sequestering of triglyceride (GO:0010889) | 3.96127088 |
| 58 | 2-oxoglutarate metabolic process (GO:0006103) | 3.95058074 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.94128403 |
| 60 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.93895300 |
| 61 | response to inactivity (GO:0014854) | 3.92041701 |
| 62 | cell communication involved in cardiac conduction (GO:0086065) | 3.91446717 |
| 63 | regulation of the force of heart contraction (GO:0002026) | 3.91133597 |
| 64 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.83524706 |
| 65 | muscle system process (GO:0003012) | 3.77813154 |
| 66 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.76433373 |
| 67 | myotube cell development (GO:0014904) | 3.75406722 |
| 68 | cytidine metabolic process (GO:0046087) | 3.73252233 |
| 69 | cytidine catabolic process (GO:0006216) | 3.73252233 |
| 70 | cytidine deamination (GO:0009972) | 3.73252233 |
| 71 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.72323838 |
| 72 | regulation of sulfur metabolic process (GO:0042762) | 3.70949244 |
| 73 | carnitine transport (GO:0015879) | 3.70028697 |
| 74 | amino-acid betaine transport (GO:0015838) | 3.70028697 |
| 75 | respiratory electron transport chain (GO:0022904) | 3.69967803 |
| 76 | oxidative phosphorylation (GO:0006119) | 3.69086470 |
| 77 | negative regulation of potassium ion transport (GO:0043267) | 3.65856490 |
| 78 | striated muscle cell development (GO:0055002) | 3.65747319 |
| 79 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.62525642 |
| 80 | striated muscle adaptation (GO:0014888) | 3.62402192 |
| 81 | cardiac muscle cell action potential (GO:0086001) | 3.60461512 |
| 82 | cellular response to epinephrine stimulus (GO:0071872) | 3.60388768 |
| 83 | electron transport chain (GO:0022900) | 3.58573753 |
| 84 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.57256888 |
| 85 | negative regulation of protein localization to cell surface (GO:2000009) | 3.55925187 |
| 86 | regulation of ATPase activity (GO:0043462) | 3.55597578 |
| 87 | regulation of ATP catabolic process (GO:1903289) | 3.55597578 |
| 88 | regulation of cardiac muscle contraction (GO:0055117) | 3.54115409 |
| 89 | response to muscle activity (GO:0014850) | 3.54111041 |
| 90 | skeletal muscle tissue development (GO:0007519) | 3.52951373 |
| 91 | positive regulation of myotube differentiation (GO:0010831) | 3.51788243 |
| 92 | regulation of heart rate (GO:0002027) | 3.51074052 |
| 93 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.50695786 |
| 94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.50695786 |
| 95 | glycogen catabolic process (GO:0005980) | 3.49745617 |
| 96 | positive regulation of cation channel activity (GO:2001259) | 3.48314697 |
| 97 | ATP synthesis coupled proton transport (GO:0015986) | 3.46276004 |
| 98 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.46276004 |
| 99 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.44022062 |
| 100 | muscle hypertrophy in response to stress (GO:0003299) | 3.44022062 |
| 101 | cardiac muscle adaptation (GO:0014887) | 3.44022062 |
| 102 | protein heterotrimerization (GO:0070208) | 3.41792788 |
| 103 | response to epinephrine (GO:0071871) | 3.40809972 |
| 104 | glycogen biosynthetic process (GO:0005978) | 3.39055749 |
| 105 | glucan biosynthetic process (GO:0009250) | 3.39055749 |
| 106 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.36611162 |
| 107 | muscle fiber development (GO:0048747) | 3.34784091 |
| 108 | oxygen transport (GO:0015671) | 3.32417791 |
| 109 | striated muscle atrophy (GO:0014891) | 3.30331150 |
| 110 | regulation of heart contraction (GO:0008016) | 3.26390218 |
| 111 | glucan catabolic process (GO:0009251) | 3.25277172 |
| 112 | cell migration involved in heart development (GO:0060973) | 3.22163401 |
| 113 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.21929463 |
| 114 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.21929463 |
| 115 | muscle organ development (GO:0007517) | 3.20016854 |
| 116 | muscle structure development (GO:0061061) | 3.16091619 |
| 117 | cellular polysaccharide catabolic process (GO:0044247) | 3.09346383 |
| 118 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.96974716 |
| 119 | muscle cell fate commitment (GO:0042693) | 2.93707710 |
| 120 | * regulation of muscle system process (GO:0090257) | 2.89783497 |
| 121 | * regulation of muscle contraction (GO:0006937) | 2.86904611 |
| 122 | triglyceride catabolic process (GO:0019433) | 2.86140793 |
| 123 | muscle cell cellular homeostasis (GO:0046716) | 2.83482454 |
| 124 | extracellular matrix assembly (GO:0085029) | 2.81867848 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 2.77626870 |
| 126 | polysaccharide catabolic process (GO:0000272) | 2.77491677 |
| 127 | regulation of myoblast differentiation (GO:0045661) | 2.76976521 |
| 128 | striated muscle tissue development (GO:0014706) | 2.76102986 |
| 129 | lipid particle organization (GO:0034389) | 2.74928180 |
| 130 | metanephric mesenchyme development (GO:0072075) | 2.71269362 |
| 131 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.70583775 |
| 132 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68965677 |
| 133 | muscle cell development (GO:0055001) | 2.66955540 |
| 134 | cell-substrate adherens junction assembly (GO:0007045) | 2.66173500 |
| 135 | focal adhesion assembly (GO:0048041) | 2.66173500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.45597110 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.09343396 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.96458827 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.93406821 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.83799932 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.83799932 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.27130592 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.19330034 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.04848937 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.93339009 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.67755693 |
| 12 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.59977779 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32012558 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.25541895 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.13789313 |
| 16 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.05607352 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.99611407 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.93600582 |
| 19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.91580191 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88827116 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88738130 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85933662 |
| 23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82509002 |
| 24 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.69710864 |
| 25 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.67387909 |
| 26 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.63982963 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62370999 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62370999 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60748590 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60636777 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58866311 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57348578 |
| 33 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.55212741 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48431217 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44212705 |
| 36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43516232 |
| 37 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42928958 |
| 38 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41452900 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39897364 |
| 40 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.39553589 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39382708 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.38961835 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38237106 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37177481 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36305582 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36232625 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35398464 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35186906 |
| 49 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33661368 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33316067 |
| 51 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33135471 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32649701 |
| 53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29641822 |
| 54 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27552049 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26017206 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25910282 |
| 57 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.23097719 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22756239 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21646264 |
| 60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20872223 |
| 61 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20250465 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19724304 |
| 63 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18762343 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18087985 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16892697 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15308970 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14695429 |
| 68 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.14097948 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12156645 |
| 70 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.11467218 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 1.10942564 |
| 72 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10518241 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08978245 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08484523 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07487748 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.06823127 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06582861 |
| 78 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.04579567 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04102681 |
| 80 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03895571 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01216263 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01212472 |
| 83 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.01020582 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00733940 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00682549 |
| 86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00597189 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00144154 |
| 88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99898869 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99884974 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99775723 |
| 91 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.99463756 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98980462 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98729085 |
| 94 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98641165 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98503486 |
| 96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97678811 |
| 97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97646733 |
| 98 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.96160599 |
| 99 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96028659 |
| 100 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95021700 |
| 101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95018976 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94929444 |
| 103 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94561248 |
| 104 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93905425 |
| 105 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93248912 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91996261 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90825740 |
| 108 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90544565 |
| 109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89505280 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89491381 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89491381 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88066166 |
| 113 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87942011 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87504608 |
| 115 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87212592 |
| 116 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86691336 |
| 117 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85463337 |
| 118 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85423201 |
| 119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85053225 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84519586 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83487970 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83104124 |
| 123 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82804665 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81872171 |
| 125 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81679467 |
| 126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81386712 |
| 127 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79914990 |
| 128 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79843552 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79466735 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78695155 |
| 131 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.77613183 |
| 132 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.77440407 |
| 133 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77383417 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76916532 |
| 135 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.76511024 |
| 136 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.74691192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.55889431 |
| 2 | MP0003646_muscle_fatigue | 6.27623182 |
| 3 | MP0000751_myopathy | 5.54837134 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.84026999 |
| 5 | MP0000749_muscle_degeneration | 4.53107024 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.22211044 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.08864131 |
| 8 | MP0005330_cardiomyopathy | 3.58459027 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.37048234 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.24806767 |
| 11 | MP0000750_abnormal_muscle_regeneration | 2.98389493 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.93191689 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.83745905 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.80189138 |
| 15 | MP0004130_abnormal_muscle_cell | 2.75782679 |
| 16 | MP0000747_muscle_weakness | 2.60808549 |
| 17 | MP0002269_muscular_atrophy | 2.60320279 |
| 18 | MP0000759_abnormal_skeletal_muscle | 2.46564788 |
| 19 | MP0003137_abnormal_impulse_conducting | 2.44176880 |
| 20 | MP0005369_muscle_phenotype | 2.41800344 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.41670758 |
| 22 | MP0004484_altered_response_of | 2.33945587 |
| 23 | MP0010630_abnormal_cardiac_muscle | 2.33888279 |
| 24 | MP0001544_abnormal_cardiovascular_syste | 2.33345663 |
| 25 | MP0005385_cardiovascular_system_phenoty | 2.33345663 |
| 26 | MP0006138_congestive_heart_failure | 2.01319948 |
| 27 | MP0004233_abnormal_muscle_weight | 1.98281940 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.81126169 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.79240034 |
| 30 | MP0003828_pulmonary_edema | 1.71895671 |
| 31 | MP0004085_abnormal_heartbeat | 1.71462155 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.67699934 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.62977223 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.62139788 |
| 35 | MP0003011_delayed_dark_adaptation | 1.50121368 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.37753076 |
| 37 | MP0005670_abnormal_white_adipose | 1.37017257 |
| 38 | MP0004510_myositis | 1.34820805 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.30597417 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.26797342 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.21995633 |
| 42 | MP0000343_altered_response_to | 1.16525828 |
| 43 | MP0005375_adipose_tissue_phenotype | 1.14751340 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.08301987 |
| 45 | MP0001661_extended_life_span | 1.06960109 |
| 46 | MP0000266_abnormal_heart_morphology | 1.02781081 |
| 47 | MP0000733_abnormal_muscle_development | 1.02629658 |
| 48 | MP0003279_aneurysm | 1.02313098 |
| 49 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96459912 |
| 50 | MP0010368_abnormal_lymphatic_system | 0.95367116 |
| 51 | MP0005165_increased_susceptibility_to | 0.93067997 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 0.92508613 |
| 53 | MP0002295_abnormal_pulmonary_circulatio | 0.91881914 |
| 54 | MP0005266_abnormal_metabolism | 0.90494319 |
| 55 | MP0005275_abnormal_skin_tensile | 0.86782964 |
| 56 | MP0000013_abnormal_adipose_tissue | 0.81639622 |
| 57 | MP0001542_abnormal_bone_strength | 0.81330126 |
| 58 | MP0002971_abnormal_brown_adipose | 0.80872605 |
| 59 | MP0004043_abnormal_pH_regulation | 0.77843211 |
| 60 | MP0000230_abnormal_systemic_arterial | 0.76011274 |
| 61 | MP0002909_abnormal_adrenal_gland | 0.73812186 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 0.73028697 |
| 63 | MP0002933_joint_inflammation | 0.72084468 |
| 64 | MP0002128_abnormal_blood_circulation | 0.70421839 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.70044756 |
| 66 | MP0003959_abnormal_lean_body | 0.69626603 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.69015496 |
| 68 | MP0005508_abnormal_skeleton_morphology | 0.67700600 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 0.66786252 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 0.59900365 |
| 71 | MP0003091_abnormal_cell_migration | 0.59226193 |
| 72 | MP0009250_abnormal_appendicular_skeleto | 0.55922342 |
| 73 | MP0005623_abnormal_meninges_morphology | 0.55710412 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.55073223 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.54097739 |
| 76 | MP0010030_abnormal_orbit_morphology | 0.53824775 |
| 77 | MP0004858_abnormal_nervous_system | 0.52481354 |
| 78 | MP0000249_abnormal_blood_vessel | 0.50737266 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.50689146 |
| 80 | MP0000767_abnormal_smooth_muscle | 0.50393195 |
| 81 | MP0004147_increased_porphyrin_level | 0.48891476 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.48570774 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.47368425 |
| 84 | MP0003879_abnormal_hair_cell | 0.46322201 |
| 85 | MP0002970_abnormal_white_adipose | 0.45890402 |
| 86 | MP0005187_abnormal_penis_morphology | 0.45622470 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.43291884 |
| 88 | MP0005023_abnormal_wound_healing | 0.43216883 |
| 89 | MP0002060_abnormal_skin_morphology | 0.43066030 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.42932483 |
| 91 | MP0005257_abnormal_intraocular_pressure | 0.42222484 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.41658472 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.40578854 |
| 94 | MP0005334_abnormal_fat_pad | 0.40563797 |
| 95 | MP0000163_abnormal_cartilage_morphology | 0.39049132 |
| 96 | MP0000579_abnormal_nail_morphology | 0.37641659 |
| 97 | MP0003195_calcinosis | 0.35851408 |
| 98 | MP0002925_abnormal_cardiovascular_devel | 0.35765170 |
| 99 | MP0005083_abnormal_biliary_tract | 0.33791223 |
| 100 | MP0005535_abnormal_body_temperature | 0.33188652 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.32699446 |
| 102 | MP0009840_abnormal_foam_cell | 0.31857804 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.31557504 |
| 104 | MP0005451_abnormal_body_composition | 0.31467614 |
| 105 | MP0001614_abnormal_blood_vessel | 0.31181096 |
| 106 | MP0004272_abnormal_basement_membrane | 0.30634257 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.30427335 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.29587878 |
| 109 | MP0003045_fibrosis | 0.29334460 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.28847864 |
| 111 | MP0001784_abnormal_fluid_regulation | 0.28280187 |
| 112 | MP0003948_abnormal_gas_homeostasis | 0.28048796 |
| 113 | MP0009115_abnormal_fat_cell | 0.27980200 |
| 114 | MP0006072_abnormal_retinal_apoptosis | 0.27962010 |
| 115 | MP0001958_emphysema | 0.27828406 |
| 116 | MP0000762_abnormal_tongue_morphology | 0.26417187 |
| 117 | MP0005503_abnormal_tendon_morphology | 0.26186837 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.24960599 |
| 119 | MP0001853_heart_inflammation | 0.24933391 |
| 120 | MP0005595_abnormal_vascular_smooth | 0.22898523 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.22322168 |
| 122 | MP0005452_abnormal_adipose_tissue | 0.22007565 |
| 123 | MP0002896_abnormal_bone_mineralization | 0.21209221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.07347336 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.74819121 |
| 3 | Sudden death (HP:0001699) | 6.73279052 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.62894750 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.41178075 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.16752739 |
| 7 | Ventricular tachycardia (HP:0004756) | 5.85574409 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 5.41034362 |
| 9 | Muscle fiber inclusion bodies (HP:0100299) | 5.33422497 |
| 10 | Myoglobinuria (HP:0002913) | 5.31947239 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 5.31469785 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.11661057 |
| 13 | Atrial fibrillation (HP:0005110) | 4.89083864 |
| 14 | Subaortic stenosis (HP:0001682) | 4.78502092 |
| 15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.78502092 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.63941896 |
| 17 | Increased connective tissue (HP:0009025) | 4.62715971 |
| 18 | Type 1 muscle fiber predominance (HP:0003803) | 4.58027704 |
| 19 | Primary atrial arrhythmia (HP:0001692) | 4.56265699 |
| 20 | Lipoatrophy (HP:0100578) | 4.50822710 |
| 21 | Nemaline bodies (HP:0003798) | 4.44003120 |
| 22 | Supraventricular tachycardia (HP:0004755) | 4.40665100 |
| 23 | Difficulty running (HP:0009046) | 4.39839144 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 4.33247996 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 4.31454691 |
| 26 | Rhabdomyolysis (HP:0003201) | 4.17238650 |
| 27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.02980253 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 4.01438135 |
| 29 | Bundle branch block (HP:0011710) | 3.99651025 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.87618358 |
| 31 | Myotonia (HP:0002486) | 3.85724500 |
| 32 | Palpitations (HP:0001962) | 3.74295282 |
| 33 | Syncope (HP:0001279) | 3.71376613 |
| 34 | Prolonged QT interval (HP:0001657) | 3.52789266 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.40515455 |
| 36 | Muscle stiffness (HP:0003552) | 3.34280500 |
| 37 | Heart block (HP:0012722) | 3.28842200 |
| 38 | Ventricular arrhythmia (HP:0004308) | 3.28750946 |
| 39 | Protrusio acetabuli (HP:0003179) | 3.25581713 |
| 40 | Deformed tarsal bones (HP:0008119) | 3.23606574 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.20810643 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 3.19714462 |
| 43 | Abnormal atrioventricular conduction (HP:0005150) | 3.16286549 |
| 44 | Slender build (HP:0001533) | 3.09118817 |
| 45 | Distal arthrogryposis (HP:0005684) | 3.07901102 |
| 46 | Myopathic facies (HP:0002058) | 3.07055351 |
| 47 | Atrioventricular block (HP:0001678) | 3.05862111 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 3.01393091 |
| 49 | Neck muscle weakness (HP:0000467) | 2.97757911 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.91566114 |
| 51 | Aortic aneurysm (HP:0004942) | 2.88230339 |
| 52 | Ventricular fibrillation (HP:0001663) | 2.86605087 |
| 53 | Round ear (HP:0100830) | 2.81905830 |
| 54 | Limb-girdle muscle atrophy (HP:0003797) | 2.69952330 |
| 55 | Rimmed vacuoles (HP:0003805) | 2.68996177 |
| 56 | Left ventricular hypertrophy (HP:0001712) | 2.55023286 |
| 57 | Hepatic necrosis (HP:0002605) | 2.53619103 |
| 58 | Bulbar palsy (HP:0001283) | 2.53239598 |
| 59 | Abnormal EKG (HP:0003115) | 2.52876479 |
| 60 | Hip contracture (HP:0003273) | 2.50822018 |
| 61 | Hypoplastic ischia (HP:0003175) | 2.47436299 |
| 62 | Ketoacidosis (HP:0001993) | 2.47168071 |
| 63 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.45386882 |
| 64 | Ulnar deviation of the wrist (HP:0003049) | 2.44913809 |
| 65 | Malignant hyperthermia (HP:0002047) | 2.41437256 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 2.39016653 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.36564584 |
| 68 | Abnormal finger flexion creases (HP:0006143) | 2.32483504 |
| 69 | Lower limb amyotrophy (HP:0007210) | 2.31134397 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 2.30692317 |
| 71 | Testicular atrophy (HP:0000029) | 2.29709128 |
| 72 | Facial diplegia (HP:0001349) | 2.29038777 |
| 73 | Palmoplantar keratoderma (HP:0000982) | 2.28128049 |
| 74 | Muscular dystrophy (HP:0003560) | 2.24799503 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.24183368 |
| 76 | Hepatocellular necrosis (HP:0001404) | 2.21519720 |
| 77 | Oligomenorrhea (HP:0000876) | 2.19571064 |
| 78 | Hypoglycemic coma (HP:0001325) | 2.17959306 |
| 79 | EMG: neuropathic changes (HP:0003445) | 2.17179232 |
| 80 | Abnormality of the ischium (HP:0003174) | 2.16642355 |
| 81 | Frequent falls (HP:0002359) | 2.15873310 |
| 82 | Premature rupture of membranes (HP:0001788) | 2.13205043 |
| 83 | Gowers sign (HP:0003391) | 2.12228483 |
| 84 | Scapular winging (HP:0003691) | 2.12128761 |
| 85 | Acute encephalopathy (HP:0006846) | 2.08309362 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05025534 |
| 87 | Central scotoma (HP:0000603) | 2.04473113 |
| 88 | Generalized muscle weakness (HP:0003324) | 2.03593409 |
| 89 | Abnormality of the calcaneus (HP:0008364) | 2.03224139 |
| 90 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.01964021 |
| 91 | Conjunctival hamartoma (HP:0100780) | 2.01767665 |
| 92 | Abnormality of the foot musculature (HP:0001436) | 2.00618221 |
| 93 | Exercise intolerance (HP:0003546) | 2.00200992 |
| 94 | Spinal rigidity (HP:0003306) | 1.98672826 |
| 95 | Foot dorsiflexor weakness (HP:0009027) | 1.97965715 |
| 96 | Mitochondrial inheritance (HP:0001427) | 1.97772716 |
| 97 | Progressive macrocephaly (HP:0004481) | 1.97704043 |
| 98 | Proximal amyotrophy (HP:0007126) | 1.95519879 |
| 99 | Dicarboxylic aciduria (HP:0003215) | 1.95383313 |
| 100 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95383313 |
| 101 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.93274863 |
| 102 | Weak cry (HP:0001612) | 1.93247030 |
| 103 | Ankle contracture (HP:0006466) | 1.91444872 |
| 104 | Waddling gait (HP:0002515) | 1.90616653 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89554618 |
| 106 | Cerebral edema (HP:0002181) | 1.89159040 |
| 107 | Generalized amyotrophy (HP:0003700) | 1.87565498 |
| 108 | Limb-girdle muscle weakness (HP:0003325) | 1.87485122 |
| 109 | Calcaneovalgus deformity (HP:0001848) | 1.87192249 |
| 110 | Limited hip movement (HP:0008800) | 1.86690097 |
| 111 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.86317731 |
| 112 | Vascular tortuosity (HP:0004948) | 1.85354132 |
| 113 | Aortic dissection (HP:0002647) | 1.85090682 |
| 114 | Progressive muscle weakness (HP:0003323) | 1.85082818 |
| 115 | Increased CSF lactate (HP:0002490) | 1.85042801 |
| 116 | Ketosis (HP:0001946) | 1.84678816 |
| 117 | Large for gestational age (HP:0001520) | 1.78140584 |
| 118 | Absent phalangeal crease (HP:0006109) | 1.77068529 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 1.77005149 |
| 120 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.76790682 |
| 121 | Abnormality of alanine metabolism (HP:0010916) | 1.76790682 |
| 122 | Hyperalaninemia (HP:0003348) | 1.76790682 |
| 123 | Fetal akinesia sequence (HP:0001989) | 1.71409854 |
| 124 | Metatarsus adductus (HP:0001840) | 1.69440671 |
| 125 | Broad metatarsal (HP:0001783) | 1.68205806 |
| 126 | Infantile muscular hypotonia (HP:0008947) | 1.65816726 |
| 127 | Hyperkalemia (HP:0002153) | 1.64560286 |
| 128 | Cerebral aneurysm (HP:0004944) | 1.63242221 |
| 129 | Fatigable weakness (HP:0003473) | 1.59364531 |
| 130 | Abnormality of the neuromuscular junction (HP:0003398) | 1.59364531 |
| 131 | Breech presentation (HP:0001623) | 1.58808475 |
| 132 | Shallow orbits (HP:0000586) | 1.57476718 |
| 133 | Steppage gait (HP:0003376) | 1.56325011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.84735654 |
| 2 | OBSCN | 5.60583174 |
| 3 | PHKG2 | 4.56210575 |
| 4 | PHKG1 | 4.56210575 |
| 5 | PDK4 | 3.12260704 |
| 6 | PDK3 | 3.12260704 |
| 7 | LMTK2 | 2.88885501 |
| 8 | DMPK | 2.87885831 |
| 9 | MYLK | 2.82248121 |
| 10 | TRIB3 | 2.74818957 |
| 11 | BCKDK | 2.48233602 |
| 12 | PKN2 | 2.42278958 |
| 13 | NEK1 | 2.23359317 |
| 14 | PINK1 | 2.20365748 |
| 15 | PIK3CA | 2.14459543 |
| 16 | MUSK | 2.12907015 |
| 17 | PDK2 | 1.98688798 |
| 18 | NME1 | 1.64995692 |
| 19 | DDR2 | 1.57123899 |
| 20 | PIK3CG | 1.54847803 |
| 21 | TIE1 | 1.54423739 |
| 22 | MAP2K3 | 1.53060134 |
| 23 | STK24 | 1.46934886 |
| 24 | EEF2K | 1.43448890 |
| 25 | MAP3K7 | 1.36143445 |
| 26 | MARK1 | 1.27749721 |
| 27 | MAPK12 | 1.24000685 |
| 28 | PAK3 | 1.14813352 |
| 29 | LIMK1 | 1.14309441 |
| 30 | MOS | 1.13031084 |
| 31 | MAP3K3 | 1.11532261 |
| 32 | PRKD1 | 1.07603843 |
| 33 | MAPKAPK3 | 1.05117718 |
| 34 | GRK7 | 1.04813673 |
| 35 | CAMK2D | 1.03583323 |
| 36 | TESK1 | 1.01871463 |
| 37 | MAP3K6 | 1.01316687 |
| 38 | ILK | 0.95602002 |
| 39 | MAPK4 | 0.89477745 |
| 40 | PRKAA1 | 0.88904681 |
| 41 | RIPK1 | 0.88169769 |
| 42 | PRKAA2 | 0.84041596 |
| 43 | TRPM7 | 0.82809021 |
| 44 | ROCK1 | 0.81893181 |
| 45 | INSRR | 0.79785869 |
| 46 | ZAK | 0.79521405 |
| 47 | STK38L | 0.76985470 |
| 48 | DYRK1B | 0.73378629 |
| 49 | EPHB1 | 0.72346941 |
| 50 | MAP3K5 | 0.71895017 |
| 51 | PAK2 | 0.70188057 |
| 52 | MAP2K1 | 0.69050998 |
| 53 | FLT3 | 0.67704676 |
| 54 | GRK1 | 0.65921855 |
| 55 | WNK4 | 0.64951408 |
| 56 | PDGFRA | 0.64910061 |
| 57 | PKN1 | 0.63099732 |
| 58 | MAP3K13 | 0.62698285 |
| 59 | STK4 | 0.62502943 |
| 60 | CDC42BPA | 0.60444075 |
| 61 | GRK5 | 0.59703281 |
| 62 | KSR2 | 0.58780817 |
| 63 | ABL2 | 0.56488372 |
| 64 | NEK9 | 0.56353281 |
| 65 | STK38 | 0.54585429 |
| 66 | AKT3 | 0.52889451 |
| 67 | CAMK4 | 0.52760595 |
| 68 | PRPF4B | 0.52353562 |
| 69 | TGFBR2 | 0.52247766 |
| 70 | ERN1 | 0.50733299 |
| 71 | PTK2 | 0.50007478 |
| 72 | MARK2 | 0.49738374 |
| 73 | MAP2K6 | 0.49618141 |
| 74 | ROCK2 | 0.47433004 |
| 75 | CAMK2B | 0.46988636 |
| 76 | SIK1 | 0.46592190 |
| 77 | TAOK1 | 0.45918872 |
| 78 | * PRKG1 | 0.45719661 |
| 79 | MAP2K4 | 0.45392028 |
| 80 | PRKD2 | 0.43395007 |
| 81 | ARAF | 0.43074479 |
| 82 | AKT2 | 0.42846771 |
| 83 | CAMK2G | 0.42813773 |
| 84 | PRKACB | 0.42518322 |
| 85 | ADRBK1 | 0.42255043 |
| 86 | RPS6KC1 | 0.41683653 |
| 87 | RPS6KL1 | 0.41683653 |
| 88 | CAMK2A | 0.40304130 |
| 89 | WNK1 | 0.39548613 |
| 90 | MAP3K11 | 0.37463034 |
| 91 | KDR | 0.36728816 |
| 92 | PTK2B | 0.36396388 |
| 93 | ICK | 0.36252220 |
| 94 | KIT | 0.35518013 |
| 95 | DAPK3 | 0.35368211 |
| 96 | LATS1 | 0.35236228 |
| 97 | RPS6KA6 | 0.35089786 |
| 98 | PTK6 | 0.34119388 |
| 99 | PRKACG | 0.32679347 |
| 100 | PRKD3 | 0.32551175 |
| 101 | PDGFRB | 0.32233271 |
| 102 | PDPK1 | 0.31967893 |
| 103 | * PRKACA | 0.31827754 |
| 104 | CAMK1 | 0.31020595 |
| 105 | EPHA3 | 0.30971277 |
| 106 | MAPK11 | 0.30939920 |
| 107 | FER | 0.30723625 |
| 108 | PRKCH | 0.27032313 |
| 109 | MAP3K1 | 0.25833277 |
| 110 | SGK3 | 0.25733054 |
| 111 | LATS2 | 0.25345008 |
| 112 | SGK2 | 0.24772477 |
| 113 | EPHB2 | 0.24511239 |
| 114 | PRKCE | 0.24287611 |
| 115 | MAPK10 | 0.23916604 |
| 116 | TBK1 | 0.23363389 |
| 117 | PRKG2 | 0.22979717 |
| 118 | RPS6KA1 | 0.22645130 |
| 119 | PDK1 | 0.22274379 |
| 120 | NME2 | 0.21889135 |
| 121 | MTOR | 0.21693730 |
| 122 | NTRK1 | 0.20803974 |
| 123 | FGFR4 | 0.20787888 |
| 124 | SGK1 | 0.20678536 |
| 125 | TAOK2 | 0.19703521 |
| 126 | MAPK7 | 0.18693784 |
| 127 | LRRK2 | 0.17123896 |
| 128 | RET | 0.17089957 |
| 129 | JAK1 | 0.16679681 |
| 130 | RPS6KA3 | 0.15688723 |
| 131 | RPS6KA2 | 0.11870973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.69981449 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.24361077 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.06850360 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.69298509 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.64757638 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40926055 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22377339 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.91360467 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.82923855 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.82298470 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.65456730 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.46504194 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26155296 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.22006099 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10635309 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.10048943 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80307699 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.73140313 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64675247 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61875360 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47107214 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.46125698 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46077163 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31934363 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.29220358 |
| 26 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.22722501 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21740869 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19736159 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12879639 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12246136 |
| 31 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.11795763 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98765776 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96696298 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90079180 |
| 35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87863689 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86359219 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84871360 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80644266 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80066324 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79809802 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79799536 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79577467 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 0.79368491 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79069598 |
| 45 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78863831 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75229900 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68925694 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 0.68219311 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66260656 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66148120 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66052326 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65787983 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.64746875 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61178640 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58407906 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.58099183 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56984318 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56662919 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55031360 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54882018 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54421870 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.52992918 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52262566 |
| 64 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52177796 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.48040823 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47166915 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46178148 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.45631829 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44807346 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44166739 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44018181 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42460283 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.42270969 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.41465144 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40063435 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38943911 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38912535 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.37822183 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37474581 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35769415 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.34861630 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34023611 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.31532063 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31363810 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.31037393 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29416372 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25710489 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25488911 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24735871 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24277520 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24276028 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.23985371 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21977949 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21262487 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20518210 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.20234875 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20195722 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.19553244 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18152977 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17830659 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.16664687 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15052737 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.13426929 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12226463 |
| 105 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12099994 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.10241707 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.10179766 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10049669 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08817859 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.08409766 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08102847 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.07976089 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07262606 |
| 114 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.05444427 |
| 115 | Gap junction_Homo sapiens_hsa04540 | 0.05417745 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05190345 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.05104076 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.05049828 |
| 119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03295949 |

